Leaders in stem cell technology innovation

Our mission is grounded on the achievements of the long standing partnership of its founders. This has combined their expertise in basic and applied developmental life sciences with commercial translation. Together they founded Roslin Cells Ltd, establishing Scotland´s advanced stem cell manufacturing capacity. From here they launched other stem cell technology companies and initiatives including Roslin Cellab and Censo Biotechnologies (now Axol Bioscience), Roslin Cell Therapy, and the European Bank for Induced Stem Cells. These yielded clinical grade and standardised human pluripotent stem cell lines and practices contributing to the current state of the art use of these resources in discovery and for advanced therapies.

Dr Paul De Sousa
PhD MSc

CEO, CSO

Over 25 years innovating developmental life science & technologies for egg and embryo development, animal cloning, human pluripotent stem cell derivation, scalable manufacturing, purification, and quality control.

Aidan Courtney
LLM Law, BA Economics

Non-executive Chairman

Over 25 years experience establishing & building conmpanies in life science and technology sectors for stem cell manufacturing, discovery and therapy.

Rooted in basic & applied developmental biology

Our mission is rooted in the depth & breadth of our founders’ professional experience across academic, industrial and clinical fields in public and private sectors. This has spanned egg and embryogenesis across species, animal cloning, neuroscience and stem cell science and manufacturing. In pluripotent stem cells his teams with interdisciplinary collaborators contributed to understanding of intra and inter cellular signalling and epigenetic mechanisms controlling their identity, and development of technologies to grow and purify cells, and charactise cell susceptability to infectious prions. This translated into defining and applying international and health authority standards to manfuacture reliable and quality assured cells actively being use for discovery and therapies.